Origin Materials, Inc. (NASDAQCM: ORGN) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
Origin Materials (NASDAQ: ORGN) faces a securities fraud investigation by Schubert Jonckheer & Kolbe LLP regarding alleged false statements about their Origin 2 manufacturing plant. A U.S. District Judge has ruled that key claims in the lawsuit will proceed, focusing on allegedly misleading statements made between February 2023 and August 2023 about the facility's production focus and timeline.
The lawsuit claims Origin's management misled investors about the Origin 2 project, which was revealed in August 2023 to face several years of delays and changes in production plans, specifically no longer producing paraxylene (PX). This revelation caused the company's stock to drop 67%.
Origin Materials (NASDAQ: ORGN) è oggetto di un'indagine per frode sui titoli da parte di Schubert Jonckheer & Kolbe LLP riguardo presunte dichiarazioni false sul loro impianto di produzione Origin 2. Un giudice della US District ha stabilito che le proposte principali nella causa procederanno, concentrandosi su presunte dichiarazioni fuorvianti rilasciate tra febbraio 2023 e agosto 2023 riguardo l'orientamento della produzione e la tempistica dell'impianto.
La causa sostiene che la direzione di Origin ha ingannato gli investitori sul progetto Origin 2, che è stato rivelato nell'agosto 2023 essere soggetto a diversi anni di ritardi e cambiamenti nei piani di produzione, in particolare che non produrrà più paraxilene (PX). Questa rivelazione ha fatto crollare il prezzo delle azioni della società del 67%.
Origin Materials (NASDAQ: ORGN) enfrenta una investigación por fraude de valores por parte de Schubert Jonckheer & Kolbe LLP sobre presuntas declaraciones falsas acerca de su planta de fabricación Origin 2. Un juez federal ha dictaminado que avanzarían las reclamaciones clave de la demanda, centradas en declaraciones supuestamente engañosas hechas entre febrero de 2023 y agosto de 2023 sobre el enfoque de producción y la cronología de la instalación.
La demanda afirma que la dirección de Origin engañó a los inversores sobre el proyecto Origin 2, que se reveló en agosto de 2023 que enfrentaba varios años de retrasos y cambios en los planes de producción, específicamente que ya no produciría paraxileno (PX). Esta revelación hizo que las acciones de la empresa cayeran un 67%.
Origin Materials (NASDAQ: ORGN)은 Origin 2 제조 공장에 대한 허위 진술 의혹으로 Schubert Jonckheer & Kolbe LLP가 제기한 증권 사기 설문에 직면해 있습니다. 미국 연방 지방법원 판사는 소송의 주요 주장이 계속 진행될 것이라고 판단했고, 시설의 생산 방향과 일정에 관한 2023년 2월에서 2023년 8월 사이에 한 허위 진술에 중점을 둡니다.
소송은 Origin 경영진이 Origin 2 프로젝트에 대해 투자자들을 오도했다고 주장하며, 2023년 8월에 생산 계획이 수년간 지연되고 변경되었다고 밝혀졌고, 특히 PX로 알려진 파라자일렌의 생산이 더 이상 이루어지지 않는다고 합니다. 이 발표로 회사 주가는 67% 하락했습니다.
Origin Materials (NASDAQ: ORGN) fait l'objet d'une enquête pour fraude sur les valeurs mobilières par Schubert Jonckheer & Kolbe LLP concernant des déclarations présumées fausses sur leur usine de fabrication Origin 2. Un juge fédéral américain a jugé que les réclamations clés de la poursuite continueraient, se concentrant sur des déclarations prétendument trompeuses faites entre février 2023 et août 2023 concernant l'orientation de la production et le calendrier de l'usine.
La poursuite affirme que la direction d'Origin a trompé les investisseurs au sujet du projet Origin 2, qui a été révélé en août 2023 être confronté à plusieurs années de retards et de changements dans les plans de production, notamment qu'il ne produirait plus de paraxyline (PX). Cette révélation a entraîné une chute du cours de l'action de l'entreprise de 67%.
Origin Materials (NASDAQ: ORGN) befindet sich in einer Wertpapierbetrugsermittlung durch Schubert Jonckheer & Kolbe LLP wegen angeblicher falscher Aussagen über ihr Origin 2 Produktionswerk. Ein US-Bezirksrichter hat entschieden, dass zentrale Ansprüche der Klage weiter verfolgt werden, mit Fokus auf angeblich irreführende Aussagen, die zwischen Februar 2023 und August 2023 gemacht wurden, über die Ausrichtung der Produktion und den Zeitplan der Anlage.
Die Klage behauptet, das Management von Origin habe Investoren über das Origin 2-Projekt in die Irre geführt, das im August 2023 offenbar mehrere Jahre Verzögerungen und Änderungen der Produktionspläne erfahren würde, insbesondere dass es kein Paraxylene (PX) mehr herstellen würde. Diese Offenlegung führte dazu, dass die Aktien des Unternehmens um 67% gefallen sind.
تواجه Origin Materials (المدرجة في ناسداك: ORGN) تحقيقاً في الاحتيال على الأوراق المالية من قبل Schubert Jonckheer & Kolbe LLP بخصوص ادعاءات كاذبة مزعومة حول مصنع Origin 2. قضى قاضٍ اتحادي أمريكي بأن المطالبات الرئيسية في الدعوى ستستمر، مع التركيز على تصريحات مضلِّلة يُزعم أنها صدرت بين فبراير 2023 واغسطس 2023 حول تركيز الإنتاج للمرفق والجدول الزمني.
تزعم الدعوى أن إدارة Origin أضلَت المستثمرين بشأن مشروع Origin 2، الذي أُعلن في أغسطس 2023 أنه سيواجه عدة سنوات من التأخير وتغييرات في خطط الإنتاج، وبالتحديد أنه لن ينتج الباراكسيلين (PX) بعد الآن. قد أدى هذا الكشف إلى انخفاض سعر سهم الشركة بنسبة 67%.
Origin Materials（纳斯达克股票代码：ORGN） 正因 Schubert Jonckheer & Kolbe LLP 就其 Origin 2 制造厂的涉嫌虚假陈述而受到证券欺诈调查。美国地区法官裁定，诉讼中的关键主张将继续进行，聚焦于在2023年2月至2023年8月之间所作的据称具有误导性的陈述，涉及该设施的生产重点和时间表。
诉讼称 Origin 的管理层对 Origin 2 项目误导投资者，该项目在2023年8月被披露将面临多年的延迟并改变生产计划，具体来说不再生产对二甲苯（PX）。这一披露导致公司股价下跌67%。
- None.
- Securities fraud lawsuit against Origin and CEO moving forward in court
- Origin 2 facility facing multi-year delays from original mid-2025 completion date
- Company allegedly made false statements about production timeline and focus
- Stock price dropped 67% following revelations about project delays
- Facility will no longer produce planned paraxylene (PX) product
On February 12, 2025, U.S. District Judge William B. Shubb ruled that key claims in a securities fraud lawsuit against Origin and its CEO will move forward. The lawsuit alleges that between February 2023 and August 2023, Origin intentionally misled investors about the production focus and timeline for its new facility, known as Origin 2. These statements allegedly caused Origin's stock price to trade at artificially inflated prices. Judge Shubb found that the complaint sufficiently alleged that the defendants made false and misleading statements with an intent to defraud. When the truth was revealed in August 2023 that the Origin 2 project would be delayed several years and no longer produce paraxylene (PX), Origin's stock fell
We are investigating potential wrongdoing by Origin's directors and officers in connection with these allegations.
If you own stock in Origin, you may have legal options. Visit our website at https://www.classactionlawyers.com/originupdate to learn more.
About Schubert Jonckheer & Kolbe LLP
Schubert Jonckheer & Kolbe represents consumers in class actions and shareholders in derivative actions against corporate officers and directors. The firm is based in
Contact
Dustin L. Schubert
Schubert Jonckheer & Kolbe LLP
dschubert@schubertlawfirm.com
Tel: 415-788-4220
View original content:https://www.prnewswire.com/news-releases/origin-materials-inc-nasdaqcm-orgn-investor-reminder-schubert-jonckheer-investigating-possible-false-claims-302553438.html
SOURCE Schubert Jonckheer & Kolbe LLP
FAQ
What are the allegations in the Origin Materials (ORGN) securities fraud lawsuit?
How much did Origin Materials (ORGN) stock drop after the Origin 2 facility delays were announced?
What did the U.S. District Judge rule regarding the Origin Materials lawsuit?
What legal options do Origin Materials (ORGN) shareholders have?
What changes were announced for the Origin 2 manufacturing facility?
